Lycorine inhibits MDA-MB-231 breast cancer cell proliferation, migration and invasion that are associated with Wnt/β-catenin signaling

Authors

DOI:

https://doi.org/10.3329/bjp.v13i2.36350

Keywords:

Breast cancer, Cell proliferation, Invasion, Lycorine, Migration

Abstract

This study was aimed to determine the effects of lycorine, a toxic crystalline alkaloid, on MDA-MB-231 breast cancer cells proliferation, migration and invasion, and to investigate the mechanism involved. The cells were cultured with different concentrations of lycorine in vitro. MTT assays were performed to determine the proliferation of cells. Transwell assays were performed to measure the migration and invasion of cells. The activation of Wnt/β-catenin signaling pathway and expression were assayed by Western blot. This study showed that proliferation, migration and invasion of MDA-MB-231 breast cancer cells could be inhibited by lycorine. Furthermore, we found that Wnt/β-catenin signaling was markedly blocked in MDA-MB-321 cells treated with lycorine. In conclusion, lycorine inhibits the proliferation, migration and invasion of MDA-MB-231 breast cancer cells that is associated with the suppression of Wnt/β-catenin signaling.

Video Clip of Methodology:

5 min 39 sec:   Click to watch

Downloads

Download data is not yet available.
Abstract
1018
Download
679 Read
357

Downloads

Additional Files

Published

2018-06-21

How to Cite

Chen, X.-L. “Lycorine Inhibits MDA-MB-231 Breast Cancer Cell Proliferation, Migration and Invasion That Are Associated With Wnt/β-Catenin Signaling”. Bangladesh Journal of Pharmacology, vol. 13, no. 2, June 2018, pp. 192-5, doi:10.3329/bjp.v13i2.36350.

Issue

Vol. 13 No. 2 (2018)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).